The General Hospital Corporation Patent Portfolio Statistics

tip_user1

The General Hospital Corporation

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of The General Hospital Corporation look like?

Assignee Art Units
Total Applications: 2,739 1,909,814
Granted Patents: 1,433 1,026,937
Grant Index 65.98% ↓ 68.5%
Abandoned/Rejected Applications: 739 (34.02%) 472,160 (31.5%)
In-Process Applications: 563 410,717
Average Grant Time: 3.29 Years ↑ 2.86 Years
Average Office Actions: 2.03 ↑ 1.72

Which Technology Area The General Hospital Corporation is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 129
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 87
1632 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 80
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 80
1647 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 78

How many patents are The General Hospital Corporation filing every year?

Year Total Applications Predicted
2022 0* 504
2021 78* 426
2020 142 453
2019 171 171
2018 199 –
2017 188 –
2016 246 –
2015 213 –
2014 183 –
2013 143 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of The General Hospital Corporation in USPTO?

Publication number: None
Application number: 17/627,975

Abstract:
–

Publication date: –
Applicant: The General Hospital Corporation
Inventors: Leblanc Pierre R

Publication number: None
Application number: 17/618,323

Abstract:
–

Publication date: –
Applicant: The General Hospital Corporation
Inventors: Derin Sevenler

Publication number: US20220228150A1
Application number: 17/616,621

Abstract:
High throughput methods utilizing spatially segregated detection systems provide a robust CRISPR-based diagnostic enabling highly sensitive detection of both DNA and RNA target molecules, with applications in multiple scenarios in human health including, for example, viral detection. Kits comprising the systems allow for point-of care applications with high-throughput processing of samples.

Publication date: –
Applicant: The General Hospital Corporation
Inventors: Deborah Hung

How are The General Hospital Corporation’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/627,975 Self-Assembled Vaccines And Combination Therapies For Treating Cancer Application Undergoing Preexam Processing – –
17/618,323 An Enzymatic Assay To Measure Long-Term Adherence To Pre Exposure Prophylaxis And Antiretroviral Therapy – – –
17/616,621 Crispr System High Throughput Diagnostic Systems And Methods Application Dispatched from Preexam, Not Yet Docketed 1636 –
17/535,493 Injectable Slurries And Methods Of Manufacturing The Same Notice of Allowance Mailed — Application Received in Office of Publications 1613 Rosenthal, Andrew S
17/611,394 Systems And Methods For Automated Image Analysis Docketed New Case – Ready for Examination OPAP Central, Docket